FDA approves mAb for multidrug-resistant HIV

FDA approved Trogarzo ibalizumab-uiyk, a humanized mAb against CD4 that prevents viral entry, to treat heavily treatment-experienced patients with HIV-1 whose infections

Read the full 225 word article

User Sign In